Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-23-004170
Filing Date
2023-06-27
Accepted
2023-06-27 14:35:00
Documents
111
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F mdna20230331_20f.htm   iXBRL 20-F 2156181
2 EXHIBIT 12.1 ex_536678.htm EX-12.1 13118
3 EXHIBIT 12.2 ex_536679.htm EX-12.2 13202
4 EXHIBIT 13.1 ex_536680.htm EX-13.1 4183
5 EXHIBIT 13.2 ex_536681.htm EX-13.2 4273
6 EXHIBIT 15.1 ex_537935.htm EX-15.1 373740
7 EXHIBIT 15.3 ex_538382.htm EX-15.3 4076
13 abc.jpg GRAPHIC 11119
14 bizaxofusp.jpg GRAPHIC 7847
15 cummulative_val.jpg GRAPHIC 32987
16 endocytosis_.jpg GRAPHIC 18185
17 exh151_p11.jpg GRAPHIC 108222
18 exh151_p12a.jpg GRAPHIC 86711
19 exh151_p14.jpg GRAPHIC 121830
20 exh151_p16a.jpg GRAPHIC 107378
21 exh151_p16b.jpg GRAPHIC 110429
22 exh151pg10.jpg GRAPHIC 130723
23 exh151pg12a.jpg GRAPHIC 102939
24 exh151pg12b.jpg GRAPHIC 101084
25 exh151pg13.jpg GRAPHIC 72538
26 f20pg31a.jpg GRAPHIC 62845
27 il2receptor.jpg GRAPHIC 25205
28 logo.jpg GRAPHIC 14116
29 mdna109.jpg GRAPHIC 24521
30 mdna223.jpg GRAPHIC 34221
31 mdna223m.jpg GRAPHIC 33903
32 noevidence.jpg GRAPHIC 25410
33 org_struc.jpg GRAPHIC 17464
34 prod_cand.jpg GRAPHIC 29814
35 pwc.jpg GRAPHIC 2425
36 superkines.jpg GRAPHIC 29019
37 treatment.jpg GRAPHIC 40951
  Complete submission text file 0001171843-23-004170.txt   10597184

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA mdna-20230331.xsd EX-101.SCH 83731
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mdna-20230331_cal.xml EX-101.CAL 39051
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mdna-20230331_def.xml EX-101.DEF 395818
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE mdna-20230331_lab.xml EX-101.LAB 345439
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mdna-20230331_pre.xml EX-101.PRE 426202
105 EXTRACTED XBRL INSTANCE DOCUMENT mdna20230331_20f_htm.xml XML 1091227
Mailing Address 2 BLOOR ST W., 7TH FLOOR TORONTO A6 M4W 3E2
Business Address 2 BLOOR ST W., 7TH FLOOR TORONTO A6 M4W 3E2 416 648-5555
Medicenna Therapeutics Corp. (Filer) CIK: 0001807983 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 0331
Type: 20-F | Act: 34 | File No.: 001-39458 | Film No.: 231046570
SIC: 2834 Pharmaceutical Preparations